美國癌症研究學會(American Association for Cancer Research) 會員
論文及期刊發表
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Above-standard survival of hepatocellular carcinoma as the final outcome of comprehensive hepatology care programs in a remote HCV-endemic area.
Niclosamide enhances sorafenib sensitivity through IGF-1R and metabolic changes in hepatocellular carcinoma.
Factors associated with large renal function decline in patients with chronic hepatitis C successfully treated with direct-acting antiviral therapy.
Direct-acting antivirals reduce the de novo development of esophageal varices in patients with hepatitis C related liver cirrhosis.
Changes in in renal function in chronic hepatitis C patients treated with sofosbuvir/velpatasvir.
Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting.
Non-B, non-C hepatocellular carcinoma in an HBV- and HCV-endemic area: A community-based prospective longitudinal study.
Targeting galectin-1 inhibits hepatoma progression by inducing ADAM17-mediated TNFR1 shedding in carcinoma-associated fibroblasts.
The novel finding of dynamic change of eGFR to one year after end-of-treatment in HCV-infected patients receiving sofosbuvir and velpatasvir.
Factors associated with significant platelet count improvement in thrombocytopenic chronic hepatitis C patients receiving direct-acting antivirals.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
Community-based screening for hepatitis B and C virus activity using two quantitative antigens to identify endemic townships.
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Fusobacterium nucleatum infection is associated with decreased survival of Helicobacter pylori-positive gastric cancer patients.
A Yes-associated protein (YAP) and insulin-like growth factor 1 receptor (IGF-1R) signaling loop is involved in sorafenib resistance in hepatocellular carcinoma.
Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV reflex HCV antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan.
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: a real-world effectiveness analysis.
Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan.
The role of IGF/IGF-1R signaling in hepatocellular carcinomas: Stemness-related properties and drug resistance.
Immuno-metabolism: The role of cancer niche in immune checkpoint inhibitor resistance.
Epigenetic silencing of STAT3-targeted miR-193a, by constitutive activation of JAK/STAT signaling, leads to tumor progression through overexpression of YWHAZ in gastric cancer.
Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B.
Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening.
Challenges of transferring rural adults with chronic HCV infection for further HCVRNA confirmation and free DAAs treatment: a success story of interdisciplinary collaboration approach.
High viral load predicts virological failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy.
2,4-diamino-quinazoline, a Wnt signaling inhibitor, suppresses gastric cancer progression and metastasis.
Real world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: a multicenter pooled analysis in Taiwan.
Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C.
Liver health literacy and health status among adults with hepatitis C: implications for the nursing profession as part of the 2030 global elimination goal.
Limited effects of antibiotic prophylaxis in patients with Child–Pugh class A/B cirrhosis and upper gastrointestinal bleeding.
Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin.
DNMT3b/OCT4 expression confers poor prognosis and sorafenib sensitivity of hepatocellular carcinoma trough IL-6/STAT-3 regulation.
Esophageal perforation caused by a central venous catheter: a case report and literature review.
An investigation of the side effects, patient feedback, and physiological changes associated with direct-acting antiviral therapy for hepatitis C.
Prevalence and predictive value of high rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.
Pretreatment inflammation-based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation.
The clinical roles of rheumatic factor in the treatment of chronic hepatitis C infection.
Inhibition of CCAR1, a coactivator of β-catenin, suppresses the proliferation and migration of gastric cancer cells
Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Inflammation promotes expression of stemness-related properties in HBV-related hepatocellular carcinoma.
Hepatoprotective effect of esveratrol against ethanol-induced oxidative stress through induction of superoxide dimutase in vivo and in vitro.
Distribution of fatal Vibrio vulnificus necrotizing skin and soft-tissue infections: a systematic review and meta-analysis.
TGF-βI regulates cell migration through pluripotent transcription factor OCT4 in endometriosis.
Response to Braillon Hepatocellular carcinoma surveillance: A strategy that merits moving forward.
Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis.
Bupivacaine induces apoptosis through caspase-dependent and -independent pathways in canine mammary tumor cells.
Activation of IL6/IGF-IR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.
Outcomes of endoscopic submucosal dissection for early gastric cancer and precancer lesion: Experience from a center in Southern Taiwan.
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.
Routine blood tests to predict liver fibrosis in chronic hepatitis C.
Serum HCV RNA level is not associated with the presence of insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection.
Antibiotic strategy for pyogenic liver abscess: one medical center experience in Taiwan.
Paraesophageal hernia complicated with mediastinal abscess: Report of a case.
FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis.
Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent
infections of hepatitis B and C virus.
Endoscopic submucosal
dissection for early gastric cancers: experience from a new endoscopic center in Taiwan.
Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience.
Effect of oral esomeprazole on
recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
Successful treatment of pancreatic ascites by endoscopic pancreatic duct stenting: Report of a case.
Strangulated obturator hernia- a rare cause of small bowel obstruction: Report of a case.
Hepatitis C virus infection facilitates gallstone formation.
Application of lugol chromoendoscopy on the diagnosis of early esophageal cancer.
Gingival metastasis from gallbladder cancer, a case report.
